Association between donor specific HLA antibodies and rejection in liver transplantation

供者特异性 HLA 抗体与肝移植排斥反应之间的关联

基本信息

  • 批准号:
    23791520
  • 负责人:
  • 金额:
    $ 2.75万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 财政年份:
    2011
  • 资助国家:
    日本
  • 起止时间:
    2011 至 2012
  • 项目状态:
    已结题

项目摘要

The role of human leukocyte antigen (HLA) antibodies in graft rejection after liver transplantation remains inconclusive. In order to investigate whether the presence of HLA antibodies was associated with rejection, we retrospectively examined the prevalence of anti-HLA antibodies in living-donor liver transplant recipients both before and after transplantation, and then analyzed the relationship of those antibodies with rejection.The prevalence of post-transplant HLA antibodies-especially donor-specific antibodies-in patients who experienced acute rejection was higher than in patients who had no rejection, though the difference did not reach statistical significance. In addition, the prevalence of antibodies before and after transplantation in patients who developed operational tolerance after withdrawal from immunosuppression was more likely to be negative than in patients who did not develop operational tolerance. Pre-transplant, the recipients who did not develop operational tolerance tended to have antibodies whose titers were already high. The highest mean fluorescence intensity of antibodies was significantly higher in patients who did not develop operational tolerance than in patients who developed operational tolerance. Therefore, not only the prevalence of antibodies but also their titers were closely associated with rejection.In our study, post-transplantation HLA antibodies were clearly associated with rejection.
人白细胞抗原(HLA)抗体在肝移植后移植排斥反应中的作用尚无定论。为了调查HLA抗体的存在是否与排斥相关,我们回顾性地检查了在活肝移植前和之后的活肝移植受者中抗HLA抗体的普遍性尽管差异没有达到统计学意义,但高于没有排斥的患者。此外,与未发展手术耐受性的患者相比,从免疫抑制退出后出现手术耐受性的患者的抗体患病率更可能为阴性。前移植前,没有发展操作耐受性的接收者往往具有滴度已经很高的抗体。在没有发展手术耐受性的患者中,抗体的最高平均荧光强度明显高于发展耐受性的患者。因此,不仅抗体的流行率,而且它们的滴度与排斥相关。在我们的研究中,移植后HLA抗体显然与排斥相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Association of preformed anti-HLA antibody with operational tolerance in pediatric living-donor liver transplantation: a possible evidence of humoral sensitization (oral presentation)
预先形成的抗 HLA 抗体与儿科活体肝移植操作耐受性的关联:体液致敏的可能证据(口头陈述)
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kayo Waki;Yasuhiko Sugawara;Kouichi Mizuta;Masaru Hirata;Junichi Kaneko;Takashi Kadowaki;Taku Aoki;Kiyoshi Hasegawa;Norihiro Kokudo;Paul I. Terasaki
  • 通讯作者:
    Paul I. Terasaki
Association of preformed anti-HLA antibody with operational tolerance in pediatric living-donor liver transplantation: a possible evidence of humoralsensitization (oral presentation)
儿科活体肝移植中预制抗 HLA 抗体与操作耐受性的关联:体液致敏的可能证据(口头报告)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kayo Waki;Yasuhiko Sugawara;Kouichi Mizuta;Masaru Hirata;Junichi Kaneko;Takashi Kadowaki;Taku Aoki;Kiyoshi Hasegawa;Norihiro Kokudo;Paul I. Terasaki
  • 通讯作者:
    Paul I. Terasaki
Predicting operational tolerance in pediatric living-donor liver transplantation by absence of HLA antibodies
通过缺乏 HLA 抗体预测儿科活体肝移植的手术耐受性
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Waki K;Sugawara Y;Mizuta K;Taniguchi M;Ozawa M;Hirata M;Nozawa M;Kaneko J;Takahashi K;Kadowaki T;Terasaki PI;Kokudo N
  • 通讯作者:
    Kokudo N
1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
1996-2011:HLA 匹配和正交叉配对长期生存和耐受性的影响。
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kadowaki T;Kokudo N
  • 通讯作者:
    Kokudo N
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WAKI Kayo其他文献

WAKI Kayo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

PANX1介导供肝肝窦内皮细胞招募受体CX3CR1+单核巨噬细胞抵抗肝移植术后MRSA感染的机制研究
  • 批准号:
    82370669
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
特异性多肽靶向PANX1调控细胞焦亡维持肝移植脓毒症免疫应答稳态的作用机制
  • 批准号:
    82302427
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CD147通过Caveolin-1介导内皮细胞损伤参与异种肝移植急性体液性排斥反应的机制研究
  • 批准号:
    82302005
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
上游视角下基于健康系统理论的肝移植受者管理模式构建与实证研究
  • 批准号:
    72374147
  • 批准年份:
    2023
  • 资助金额:
    40.00 万元
  • 项目类别:
    面上项目
Ox-mtDNA通过促进肝巨噬细胞焦亡诱导肝移植缺血再灌注损伤的机制研究
  • 批准号:
    82302010
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

肝移植後の抗体関連拒絶制御に向けた新規バイオマーカー探索
寻找肝移植后抗体相关排斥控制的新生物标志物
  • 批准号:
    22K08750
  • 财政年份:
    2022
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Optimization of immunosuppressive strategy for antibody mediated rejection in liver transplantation through HLA epitope
HLA表位优化肝移植抗体介导排斥反应的免疫抑制策略
  • 批准号:
    21J13724
  • 财政年份:
    2021
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Elucidation of the Mechanism of Rejection after Liver Transplantation by Epitope Analysis of HLA
HLA表位分析阐明肝移植后排斥机制
  • 批准号:
    20K22950
  • 财政年份:
    2020
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The development of treatment and analysis for the mechanism on cholestatic liver disease by using humanized mouse model
胆汁淤积性肝病人源化小鼠模型治疗进展及机制分析
  • 批准号:
    19K09064
  • 财政年份:
    2019
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of complement-binding donor-specific HLA antibody and IgG subclass in chronic rejection after organ transplantation
补体结合供体特异性 HLA 抗体和 IgG 亚类在器官移植后慢性排斥反应中的作用
  • 批准号:
    17K16502
  • 财政年份:
    2017
  • 资助金额:
    $ 2.75万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了